Propensity-matched analysis of the protective effect of ticagrelor versus clopidogrel on the risk of developing Staphylococcus aureus bacteremia

•Ticagrelor has beneficial properties against Staphylococcus aureus.•The protective effect of ticagrelor vs. clopidogrel on developing S. aureus bacteremia (SAB) was evaluated.•Ticagrelor use was associated with a statistically significant lower rate of SAB.•Further prospective studies evaluating ti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of antimicrobial agents 2023-04, Vol.61 (4), p.106752-106752, Article 106752
Hauptverfasser:	Gentry, Chris A., Whitman, Charles M., Kliewer, Brian S., Williams, Riley J., Thind, Sharanjeet K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - chemically induced Acute Coronary Syndrome - drug therapy Bloodstream infection Clopidogrel Clopidogrel - therapeutic use Humans Platelet Aggregation Inhibitors - adverse effects Retrospective Studies Staphylococcal Infections - drug therapy Staphylococcus aureus Ticagrelor Ticagrelor - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!